Does Leptin Play a Role in the Pathogenesis of Human Nonalcoholic Steatohepatitis?

Naga Chalasani, David Crabb, Oscar Cummings, Paul Y. Kwo, Ali Asghar, Prashant K. Pandya, Robert Considine

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

OBJECTIVES: Obesity is a risk factor for nonalcoholic steatohepatitis (NASH). Leptin plays an important role in the regulation of food intake, body composition, energy expenditure, and body weight. It has been suggested that leptin plays a role in the pathogenesis of NASH; however, adequate studies are lacking. We therefore conducted a study to explore the role of serum leptin in the pathogenesis of human NASH. METHODS: We measured the levels of serum leptin and its anthropometric, biochemical, metabolic, and histological correlates in a cohort of patients with NASH (n = 26) and well-matched controls (n = 20). Furthermore, we measured the levels of leptin in the serum and hepatic leptin and leptin receptor messenger RNA (mRNA) expression in liver biopsy specimens of patients with NASH (n = 5) and simple steatosis (n = 5). RESULTS: Serum leptin was not statistically different between patients with NASH and their controls (21 ± 13 vs 18 ± 11 ng/ml, respectively, p = 0.5). There was no correlation between serum leptin and hepatic histology, serum transaminases, fasting insulin levels, or a measure of insulin resistance. After adjusting for covariates in a multiple regression analysis, only percent body fat (p = 0.04) and subcutaneous abdominal fat area (p = 0.04) had significant correlation with serum leptin. There was no expression of leptin mRNA in the cell lysate of liver biopsy specimens of subjects with NASH or steatosis. Additionally, the serum leptin levels and the hepatic leptin receptor mRNA expression were not statistically different between patients with NASH and those with simple steatosis. CONCLUSION: These data do not support a direct role for leptin in the pathogenesis of human NASH.

Original languageEnglish
Pages (from-to)2771-2776
Number of pages6
JournalAmerican Journal of Gastroenterology
Volume98
Issue number12
DOIs
StatePublished - Dec 2003

Fingerprint

Leptin
Serum
Liver
Leptin Receptors
Messenger RNA
Non-alcoholic Fatty Liver Disease
Abdominal Subcutaneous Fat
Appetite Regulation
Biopsy
Transaminases
Body Composition
Energy Metabolism
Insulin Resistance
Adipose Tissue
Fasting
Histology
Obesity
Body Weight
Regression Analysis
Insulin

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Does Leptin Play a Role in the Pathogenesis of Human Nonalcoholic Steatohepatitis? / Chalasani, Naga; Crabb, David; Cummings, Oscar; Kwo, Paul Y.; Asghar, Ali; Pandya, Prashant K.; Considine, Robert.

In: American Journal of Gastroenterology, Vol. 98, No. 12, 12.2003, p. 2771-2776.

Research output: Contribution to journalArticle

@article{fe3d856d88ab425488a2083eb478b5d5,
title = "Does Leptin Play a Role in the Pathogenesis of Human Nonalcoholic Steatohepatitis?",
abstract = "OBJECTIVES: Obesity is a risk factor for nonalcoholic steatohepatitis (NASH). Leptin plays an important role in the regulation of food intake, body composition, energy expenditure, and body weight. It has been suggested that leptin plays a role in the pathogenesis of NASH; however, adequate studies are lacking. We therefore conducted a study to explore the role of serum leptin in the pathogenesis of human NASH. METHODS: We measured the levels of serum leptin and its anthropometric, biochemical, metabolic, and histological correlates in a cohort of patients with NASH (n = 26) and well-matched controls (n = 20). Furthermore, we measured the levels of leptin in the serum and hepatic leptin and leptin receptor messenger RNA (mRNA) expression in liver biopsy specimens of patients with NASH (n = 5) and simple steatosis (n = 5). RESULTS: Serum leptin was not statistically different between patients with NASH and their controls (21 ± 13 vs 18 ± 11 ng/ml, respectively, p = 0.5). There was no correlation between serum leptin and hepatic histology, serum transaminases, fasting insulin levels, or a measure of insulin resistance. After adjusting for covariates in a multiple regression analysis, only percent body fat (p = 0.04) and subcutaneous abdominal fat area (p = 0.04) had significant correlation with serum leptin. There was no expression of leptin mRNA in the cell lysate of liver biopsy specimens of subjects with NASH or steatosis. Additionally, the serum leptin levels and the hepatic leptin receptor mRNA expression were not statistically different between patients with NASH and those with simple steatosis. CONCLUSION: These data do not support a direct role for leptin in the pathogenesis of human NASH.",
author = "Naga Chalasani and David Crabb and Oscar Cummings and Kwo, {Paul Y.} and Ali Asghar and Pandya, {Prashant K.} and Robert Considine",
year = "2003",
month = "12",
doi = "10.1111/j.1572-0241.2003.08767.x",
language = "English",
volume = "98",
pages = "2771--2776",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Does Leptin Play a Role in the Pathogenesis of Human Nonalcoholic Steatohepatitis?

AU - Chalasani, Naga

AU - Crabb, David

AU - Cummings, Oscar

AU - Kwo, Paul Y.

AU - Asghar, Ali

AU - Pandya, Prashant K.

AU - Considine, Robert

PY - 2003/12

Y1 - 2003/12

N2 - OBJECTIVES: Obesity is a risk factor for nonalcoholic steatohepatitis (NASH). Leptin plays an important role in the regulation of food intake, body composition, energy expenditure, and body weight. It has been suggested that leptin plays a role in the pathogenesis of NASH; however, adequate studies are lacking. We therefore conducted a study to explore the role of serum leptin in the pathogenesis of human NASH. METHODS: We measured the levels of serum leptin and its anthropometric, biochemical, metabolic, and histological correlates in a cohort of patients with NASH (n = 26) and well-matched controls (n = 20). Furthermore, we measured the levels of leptin in the serum and hepatic leptin and leptin receptor messenger RNA (mRNA) expression in liver biopsy specimens of patients with NASH (n = 5) and simple steatosis (n = 5). RESULTS: Serum leptin was not statistically different between patients with NASH and their controls (21 ± 13 vs 18 ± 11 ng/ml, respectively, p = 0.5). There was no correlation between serum leptin and hepatic histology, serum transaminases, fasting insulin levels, or a measure of insulin resistance. After adjusting for covariates in a multiple regression analysis, only percent body fat (p = 0.04) and subcutaneous abdominal fat area (p = 0.04) had significant correlation with serum leptin. There was no expression of leptin mRNA in the cell lysate of liver biopsy specimens of subjects with NASH or steatosis. Additionally, the serum leptin levels and the hepatic leptin receptor mRNA expression were not statistically different between patients with NASH and those with simple steatosis. CONCLUSION: These data do not support a direct role for leptin in the pathogenesis of human NASH.

AB - OBJECTIVES: Obesity is a risk factor for nonalcoholic steatohepatitis (NASH). Leptin plays an important role in the regulation of food intake, body composition, energy expenditure, and body weight. It has been suggested that leptin plays a role in the pathogenesis of NASH; however, adequate studies are lacking. We therefore conducted a study to explore the role of serum leptin in the pathogenesis of human NASH. METHODS: We measured the levels of serum leptin and its anthropometric, biochemical, metabolic, and histological correlates in a cohort of patients with NASH (n = 26) and well-matched controls (n = 20). Furthermore, we measured the levels of leptin in the serum and hepatic leptin and leptin receptor messenger RNA (mRNA) expression in liver biopsy specimens of patients with NASH (n = 5) and simple steatosis (n = 5). RESULTS: Serum leptin was not statistically different between patients with NASH and their controls (21 ± 13 vs 18 ± 11 ng/ml, respectively, p = 0.5). There was no correlation between serum leptin and hepatic histology, serum transaminases, fasting insulin levels, or a measure of insulin resistance. After adjusting for covariates in a multiple regression analysis, only percent body fat (p = 0.04) and subcutaneous abdominal fat area (p = 0.04) had significant correlation with serum leptin. There was no expression of leptin mRNA in the cell lysate of liver biopsy specimens of subjects with NASH or steatosis. Additionally, the serum leptin levels and the hepatic leptin receptor mRNA expression were not statistically different between patients with NASH and those with simple steatosis. CONCLUSION: These data do not support a direct role for leptin in the pathogenesis of human NASH.

UR - http://www.scopus.com/inward/record.url?scp=0347364706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347364706&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2003.08767.x

DO - 10.1111/j.1572-0241.2003.08767.x

M3 - Article

VL - 98

SP - 2771

EP - 2776

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 12

ER -